Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Mitsudomi

Showing results (1-10 of 336) with videos related to

Pageof 34
Sort By:
Kyobu Geka. the Japanese Journal of Thoracic Surgery|May 23, 2007
[Molecular biology in diagnosis and treatment of lung cancer]Tetsuya Mitsudomi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2009
[Small-molecule tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR)]Tetsuya Mitsudomi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 20, 2013
[Driver gene mutation and targeted therapy of lung cancer]Tetsuya Mitsudomi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 14, 2002
Molecular lesions as targets for diagnosis and therapy of lung cancerTetsuya Mitsudomi
Japanese Journal of Clinical Oncology|December 25, 2009
Advances in target therapy for lung cancerTetsuya Mitsudomi
Translational Lung Cancer Research|March 26, 2015
Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutationsTetsuya Mitsudomi
Translational Lung Cancer Research|January 25, 2021
Emerging oncogenic fusions other than <i>ALK</i>, <i>ROS1</i>, <i>RET</i>, and <i>NTRK</i> in NSCLC and the role of fusions as resistance mechanisms to targeted therapyKenichi Suda, Tetsuya Mitsudomi
Kyobu Geka. the Japanese Journal of Thoracic Surgery|February 9, 2017
[Molecular Biology for Surgical Treatment of Lung Cancer]Kenichi Suda, Tetsuya Mitsudomi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 10, 2007
[Gefitinib and epidermal growth factor receptor gene mutation]Takayuki Fukui, Tetsuya Mitsudomi
Pathology International|May 12, 2007
Epidermal growth factor receptor mutations in lung cancersYasushi Yatabe, Tetsuya Mitsudomi
Pageof 34

Showing results (1-10 of 336) with videos related to

Sort By:
Pageof 34
Kyobu Geka. the Japanese Journal of Thoracic Surgery|May 23, 2007
[Molecular biology in diagnosis and treatment of lung cancer]Tetsuya Mitsudomi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2009
[Small-molecule tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR)]Tetsuya Mitsudomi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 20, 2013
[Driver gene mutation and targeted therapy of lung cancer]Tetsuya Mitsudomi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 14, 2002
Molecular lesions as targets for diagnosis and therapy of lung cancerTetsuya Mitsudomi
Japanese Journal of Clinical Oncology|December 25, 2009
Advances in target therapy for lung cancerTetsuya Mitsudomi
Translational Lung Cancer Research|March 26, 2015
Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutationsTetsuya Mitsudomi
Translational Lung Cancer Research|January 25, 2021
Emerging oncogenic fusions other than <i>ALK</i>, <i>ROS1</i>, <i>RET</i>, and <i>NTRK</i> in NSCLC and the role of fusions as resistance mechanisms to targeted therapyKenichi Suda, Tetsuya Mitsudomi
Kyobu Geka. the Japanese Journal of Thoracic Surgery|February 9, 2017
[Molecular Biology for Surgical Treatment of Lung Cancer]Kenichi Suda, Tetsuya Mitsudomi
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 10, 2007
[Gefitinib and epidermal growth factor receptor gene mutation]Takayuki Fukui, Tetsuya Mitsudomi
Pathology International|May 12, 2007
Epidermal growth factor receptor mutations in lung cancersYasushi Yatabe, Tetsuya Mitsudomi
Pageof 34